In November 2025, Novo Nordisk lowered its standard self-pay price for most doses of Wegovy and Ozempic to $349 per month, with a limited-time introductory price of $199 per month for new self-pay patients on the two lowest doses
The refined TED outcome, which focuses on pathognomonic manifestations, followed the same trend, showing a protective effect at all time points, including a one-year risk of 0.42% in the GLP-1 group compared to 0.53% in the control group (HR 0.79)
#MUSE #IHC #Immunofluorescence #SignalAmplification #ProteinDetection #Biotech #LifeSciences #Biomarkers #SpatialBiology #Neuroscience To view or add a comment, sign in TIDES: Oligonucleotides and Peptide Therapeutics | Wednesday 8:30 AM Proud to share our latest data on deep brain delivery of siRNA from rodents to NHPs
Hao L, Mi J, Song L, Guo Y, Li Y, Yin Y, et al
Extensive leukoaraiosis is associated with high early risk of recurrence after ischemic stroke